Clinical trials are essential to advancing Alzheimer’s disease research at a time when Alzheimer’s is reaching epidemic proportions. Through clinical studies conducted over the last 20 years, scientists have made tremendous strides in understanding how Alzheimer’s affects the brain. It is only through clinical studies that we will develop and test promising new strategies for treatment, prevention, diagnosis, and ultimately, a cure for Alzheimer’s disease.
To learn more about how to participate in clinical trial, watch the video below about TrialMatch (a free, clinical-trial matching service).
Have you ever heard that using aluminum pots or drinking from aluminum cans can increase your risk for developing Alzheimer’s disease? Despite the prevalence of this myth, very few experts believe that everyday sources of aluminum pose any threat. In fact, several studies have failed to confirm any role of aluminum in Alzheimer’s disease.
Some key points to consider:
Most researchers and mainstream health care professionals believe, based on current knowledge, that consumption of aluminum is not a significant risk factor for Alzheimer’s disease.
It is unlikely that people can significantly reduce their consumption of aluminum by avoiding aluminum containing cookware, foil, beverage cans, medications, or other products.
The exact role (if any) of aluminum in Alzheimer’s disease is still being research and debated.
If aluminum exposure had a major impact on risk, scientists would have already gained a clearer picture of its involvement over the decades that they have been studying the issue.
Research studies since the 1960s have failed to document a clear role for aluminum in causing Alzheimer’s disease.
Although the results of some studies have suggested that consumption of aluminum may be linked to Alzheimer’s, just as many studies have found no link between aluminum consumption and Alzheimer’s.
To learn more about myth and Alzheimer’s disease, click here.
Alzheimer's Activities and More! 